Geovax's next-generation covid-19 vaccine shows high immunogenicity in immunocompromised patients

New and unpublished data from phase 2 open-label safety study of geo-cm04s1 presented at two recent scientific meetings
GOVX Ratings Summary
GOVX Quant Ranking